Abstract
Ticarcillin was administered to three groups of patients in chronic renal failure; three were undergoing chronic hemodialysis, two were undergoing peritoneal dialysis, and three received the drug after hemodialysis. The serum half-lives were measured. A dosage regime for patients undergoing dialysis is suggested.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Eastwood J. B., Curtis J. R. Carbenicillin administration in patients with severe renal failure. Br Med J. 1968 Feb 24;1(5590):486–487. doi: 10.1136/bmj.1.5590.486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sutherland R., Wise P. J. -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: absorption and excretion in man. Antimicrob Agents Chemother (Bethesda) 1970;10:402–406. doi: 10.1128/AAC.10.3.402. [DOI] [PubMed] [Google Scholar]